Dr. Francis Collins featured our Science paper on the NIH Director’s Blog.
The study, led by Gregory Ippolito and Jason Lavinder analyzed the complete repertoire of antibodies against the spike protein from four people soon after their recoveries from mild COVID-19.
The first author of the study is William Voss, a graduate student at UT Austin. In addition to Lavinder and Ippolito, senior authors from UT Austin are Jimmy Gollihar, Ilya Finkelstein, Brent Iverson, Jason McLellan and George Georgiou. Georgiou is a professor in the McKetta Department of Chemical Engineering and at UT Austin’s Dell Medical School. Gollihar is also affiliated with the Army Research Laboratory South.